logo

Creatinine Assay Kits Market Size (2024 - 2029)

The creatinine assay kits market is experiencing growth driven by the increasing incidence of kidney diseases and chronic disorders, alongside technological advancements in biomedical research. The demand for these kits has been propelled by the heightened need for diagnosing kidney conditions, particularly following the COVID-19 pandemic, which revealed a significant correlation between the virus and acute kidney injuries. Despite the market's expansion, challenges such as the identification of novel renal biomarkers and the limited application of these kits in in-vitro diagnostic devices pose obstacles to its growth.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Consumables Research Laboratory Supplies Research Assays Research Creatinine Assay Kits Market Market Size

Market Size of Creatinine Assay Kits Industry

Creatinine Assay Kits Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 5.30 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Creatinine Assay Kits Market Major Players

*Disclaimer: Major Players sorted in no particular order

Creatinine Assay Kits Market Analysis

The creatinine assay kits market is expected to register a CAGR of 5.3% during the forecast period.

  • There was a significant COVID-19 impact observed on the market studied. This was majorly attributed to the occurrence of kidney diseases among the individuals who suffered from COVID-19. The patients who survived COVID-19 exhibited an increased risk of acute kidney injury (AKI), estimated glomerular filtration rate (eGFR) declined, end-stage kidney disease (ESKD), and significant adverse kidney events (MAKE). The risks (and burdens) of kidney outcomes increased according to the severity of the acute infection. Thus, due to the high incidence rate of COVID-19, the burden of kidney diseases increased worldwide, which propelled the demand for creatinine assay kits to detect and diagnose kidney diseases and boosted the growth of the market studied. However, the market studied is currently performing at a pre-pandemic pace as COVID-19 illness and its associated impact have declined.
  • The increasing incidence of renal and other chronic disorders, technological advancements in biomedical research about kidney disorders, and increasing research and development initiatives are the key driving factors in the creatinine assay kits market. Creatinine assay kits measure creatinine levels in serum/plasma, urine, and other biological samples. Creatinine assay is used to analyze the protein metabolism in the body, and the creatinine levels can be affected by changes in muscle mass, pregnancy, cancer, etc. Creatinine levels in the blood will increase and deflect in the blood test if the kidney is not in good condition. The creatinine test is performed by using a specific creatinine assay kit and can be performed for different conditions like hypertension, diabetes, and cancers. 
  • According to the International Society of Nephrology 2021 data, yearly, approximately 13.3 million cases of acute kidney injury (AKI) globally are exceptionally high in emerging countries, where annual incidence is estimated to be 11.3 million. Hence, with the increasing burden of kidney diseases, there is a growing demand for creatinine assay kits for diagnosis purposes, fueling the market growth worldwide.
  • Furthermore, as per Globocan, the burden of cancer is expected to reach 605,726 cases by 2040. The high burden of kidney cancer boosted the early detection of kidney diseases, thereby driving the renal biomarkers market. According to the research study published in April 2021, titled, Global epidemiology of end-stage kidney disease (ESKD) and disparities in kidney replacement therapy, end-stage kidney disease (ESKD) was a rapidly increasing global health and healthcare burden, and the average number of new ESKD diagnoses worldwide was 144 individuals per million general population. Thus, the demand for renal biomarkers for detecting and diagnosing ESKD is expected to increase, likely to boost the growth in the market studied.
  • However, identifying novel renal biomarkers and the limited usage of creatinine assay kits in in-vitro diagnostic devices hinder the global market growth.

Creatinine Assay Kits Industry Segmentation

As per the scope of this report, creatinine assay kits are used to measure creatinine levels in serum/plasma, urine, and other biological samples. The creatinine assay kits market is segmented by type (Jaffe's kinetic test kits, creatinine-PAP test kits, and ELISA test kits), type of sample (blood/serum, urine, and other samples), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type
Jaffe's Kinetic Test kits
Creatinine-PAP Test kits
ELISA Test kits
By Type of Sample
Blood/Serum
Urine
Other Samples
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Creatinine Assay Kits Market Size Summary

The creatinine assay kits market is poised for steady growth, driven by the increasing prevalence of renal and chronic disorders, alongside technological advancements in biomedical research. These kits play a crucial role in measuring creatinine levels in various biological samples, serving as a vital tool for analyzing protein metabolism and assessing kidney function. The market experienced a significant boost during the COVID-19 pandemic due to the heightened incidence of kidney-related complications among survivors, which underscored the importance of these diagnostic tools. However, the market is now stabilizing to pre-pandemic levels as the direct impacts of COVID-19 have diminished. The demand for creatinine assay kits is further fueled by the rising incidence of conditions such as hypertension, diabetes, and cancer, which necessitate regular kidney function monitoring.

North America is anticipated to maintain a significant share of the global market, supported by the high prevalence of chronic kidney disease and advancements in renal research within the region. The market is characterized by intense competition and fragmentation, with major players like Abbott Laboratories, Thermo Fisher Scientific, and Merck KGaA leading the charge. Strategic initiatives, including product launches and collaborations, are expected to drive further market expansion. For instance, recent developments such as the introduction of new enzymes for creatinine assay kits and the launch of innovative diagnostic systems in Europe highlight the ongoing efforts to enhance kidney care and early disease detection. These activities, coupled with favorable reimbursement policies and a robust healthcare infrastructure, are likely to sustain the market's growth trajectory over the forecast period.

Explore More

Creatinine Assay Kits Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Incidence of Renal and Other Chronic Disorders Impacting Renal Function

      2. 1.2.2 Technological Advancements in Biomedical Research Pertaining to Kidney Disorders

      3. 1.2.3 Increasing Research and Development Initiatives

    3. 1.3 Market Restraints

      1. 1.3.1 Identification of Novel Renal Dysfunction Biomarkers

      2. 1.3.2 Limited Usage of Creatinine Assay Kits in Invitro Diagnostic Device (IVD)

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - in USD million)

    1. 2.1 By Type

      1. 2.1.1 Jaffe's Kinetic Test kits

      2. 2.1.2 Creatinine-PAP Test kits

      3. 2.1.3 ELISA Test kits

    2. 2.2 By Type of Sample

      1. 2.2.1 Blood/Serum

      2. 2.2.2 Urine

      3. 2.2.3 Other Samples

    3. 2.3 By Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Creatinine Assay Kits Market Size FAQs

The Creatinine Assay Kits Market is projected to register a CAGR of 5.30% during the forecast period (2024-2029)

Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Quidel Corporation and Cell Biolabs, Inc are the major companies operating in the Creatinine Assay Kits Market.

Creatinine Assay Kits Report Snapshots

Creatinine Assay Kits Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)